MILLENNIUM MANAGEMENT LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$25,482,681
-52.6%
1,605,714
-43.6%
0.01%
-50.0%
Q2 2023$53,739,175
+361390.5%
2,847,863
-26.4%
0.03%
+188.9%
Q1 2023$14,866
+142.9%
3,871,424
+213.8%
0.01%
+125.0%
Q4 2022$6,119
-99.9%
1,233,720
-50.7%
0.00%
-42.9%
Q3 2022$11,964,000
-49.4%
2,503,037
-52.4%
0.01%
-53.3%
Q2 2022$23,657,000
+38.1%
5,257,049
+46.0%
0.02%
+66.7%
Q1 2022$17,136,000
-55.2%
3,600,017
-30.1%
0.01%
-52.6%
Q4 2021$38,208,000
+121.1%
5,149,291
+69.0%
0.02%
+90.0%
Q3 2021$17,279,000
-3.7%
3,047,521
+11.9%
0.01%
-9.1%
Q2 2021$17,944,000
-7.4%
2,722,908
+13.8%
0.01%
-21.4%
Q1 2021$19,378,000
+53.8%
2,392,301
+22.5%
0.01%
+55.6%
Q4 2020$12,600,000
-26.4%
1,953,474
-58.9%
0.01%
-57.1%
Q3 2020$17,119,000
-6.6%
4,755,374
+19.3%
0.02%
-16.0%
Q2 2020$18,336,000
+171.8%
3,985,994
+101.5%
0.02%
+66.7%
Q1 2020$6,746,000
-55.5%
1,978,258
-33.4%
0.02%
-21.1%
Q4 2019$15,160,000
+160.7%
2,969,579
+23.6%
0.02%
+111.1%
Q3 2019$5,814,000
-0.7%
2,402,854
-10.9%
0.01%0.0%
Q2 2019$5,855,000
-33.6%
2,698,055
-17.1%
0.01%
-30.8%
Q1 2019$8,820,000
-69.0%
3,254,576
-45.0%
0.01%
-70.5%
Q4 2018$28,417,000
+258.4%
5,920,360
+607.2%
0.04%
+340.0%
Q3 2018$7,928,000
+178.8%
837,142
+186.5%
0.01%
+233.3%
Q2 2018$2,844,000
-84.1%
292,204
-82.8%
0.00%
-87.5%
Q1 2018$17,857,000
-5.3%
1,697,382
-42.3%
0.02%
-7.7%
Q4 2017$18,855,000
-34.9%
2,941,487
-22.3%
0.03%
-40.9%
Q3 2017$28,974,000
+1.1%
3,787,427
-6.0%
0.04%
-13.7%
Q2 2017$28,649,000
+568.9%
4,029,457
+264.1%
0.05%
+537.5%
Q1 2017$4,283,000
-5.3%
1,106,695
-50.1%
0.01%
-11.1%
Q4 2016$4,525,000
-6.9%
2,218,350
+22.3%
0.01%
+12.5%
Q3 2016$4,862,000
-2.8%
1,814,320
+11.7%
0.01%
-27.3%
Q2 2016$5,003,000
+1091.2%
1,624,508
+5152.9%
0.01%
+1000.0%
Q4 2015$420,000
-97.2%
30,926
-98.0%
0.00%
-96.6%
Q3 2015$14,930,000
-73.8%
1,555,230
-60.8%
0.03%
-73.1%
Q2 2015$57,071,000
+578.6%
3,968,772
+322.4%
0.11%
+575.0%
Q1 2015$8,410,000
-24.5%
939,664
-48.5%
0.02%
-30.4%
Q4 2014$11,134,000
+617.9%
1,825,235
+1145.9%
0.02%
+475.0%
Q3 2014$1,551,000
-11.6%
146,500
-1.0%
0.00%
-20.0%
Q2 2014$1,754,000
+17.5%
147,994
+48.0%
0.01%
+25.0%
Q1 2014$1,493,000
+1.8%
100,0000.0%0.00%
-20.0%
Q4 2013$1,467,000
+25.6%
100,000
+45.7%
0.01%
+25.0%
Q3 2013$1,168,00068,6350.00%
Other shareholders
IMMUNOGEN INC shareholders Q1 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders